Pasithea Therapeutics Corp (KTTA)
5.46
-0.39
(-6.67%)
USD |
NASDAQ |
May 31, 16:00
5.55
+0.09
(+1.65%)
After-Hours: 20:00
Pasithea Therapeutics Total Assets (Quarterly): 22.41M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 22.41M |
December 31, 2023 | 26.12M |
September 30, 2023 | 30.66M |
June 30, 2023 | 38.15M |
March 31, 2023 | 42.04M |
December 31, 2022 | 45.18M |
September 30, 2022 | 49.61M |
Date | Value |
---|---|
June 30, 2022 | 53.03M |
March 31, 2022 | 51.08M |
December 31, 2021 | 53.32M |
September 30, 2021 | 21.04M |
June 30, 2021 | 0.9248M |
March 31, 2021 | 1.140M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.9248M
Minimum
Jun 2021
53.32M
Maximum
Dec 2021
33.44M
Average
38.15M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
CEL-SCI Corp | 30.05M |
AIM ImmunoTech Inc | 16.19M |
IGC Pharma Inc | 11.26M |
NovaBay Pharmaceuticals Inc | 5.357M |
Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.525M |
Shareholders Equity (Quarterly) | 19.88M |